2-Fluoroneplanocin A
2-Fluoroneplanocin A is an Antiviral agent. 2-Fluoroneplanocin A inhibits rabbit Adenosylhomocysteine hydrolase with an IC50 of 0.20 μg/mL. 2-Fluoroneplanocin A exhibits antiviral activity against vaccinia virus, vesicular stomatitis virus, parainfluenza virus, reovirus, Junín virus, Tacaribe virus, cytomegalovirus, measles virus, mumps virus, and thymidine kinase-deficient varicella-zoster virus; it shows no antiviral activity against herpes simplex virus, coxsackievirus B4, poliovirus type 1, Semliki Forest virus, or HIV at subtoxic concentrations. 2-Fluoroneplanocin A can be used in research related to vaccinia virus infection, vesicular stomatitis virus infection, parainfluenza virus infection, reovirus infection, Junín virus infection, Tacaribe virus infection, human cytomegalovirus infection, measles virus infection, mumps virus infection, and varicella-zoster virus infection.
For research use only. We do not sell to patients.
- CAS No.: 138751-31-2
- Formula: C11H12FN5O3
- Molecular Weight:281.24
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CCRF-CEM | IC50 |
1.75 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects againstTK-VZV virus expressed in CEM cells
Antiviral and cytostatic effects againstTK-VZV virus expressed in CEM cells
|
[PMID: 8809173] |
| Vero | IC50 |
0.25 μg/mL
|
Antiviral activity against vesicular stomatitis virus in Vero cells assessed by reduction of virus-induced cytopathic effect after 37 h incubation.
Antiviral activity against vesicular stomatitis virus in Vero cells assessed by reduction of virus-induced cytopathic effect after 37 h incubation.
|
8809173 |
| E6SM | IC50 |
40 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects againstTK-VZV virus expressed in E6SM cells
Antiviral and cytostatic effects againstTK-VZV virus expressed in E6SM cells
|
[PMID: 8809173] |
| Vero | IC50 |
0.03 μg/mL
|
Antiviral activity against measles virus in Vero cells assessed by reduction of virus-induced cytopathic effect after 37 h incubation.
Antiviral activity against measles virus in Vero cells assessed by reduction of virus-induced cytopathic effect after 37 h incubation.
|
8809173 |
| E6SM | IC50 |
5 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against CMV (Davis) virus expressed in E6SM HEL cells
Antiviral and cytostatic effects against CMV (Davis) virus expressed in E6SM HEL cells
|
[PMID: 8809173] |
| Vero | IC50 |
1.2 μg/mL
|
Antiviral activity against mumps virus in Vero cells assessed by reduction of virus-induced cytopathic effect after 37 h incubation.
Antiviral activity against mumps virus in Vero cells assessed by reduction of virus-induced cytopathic effect after 37 h incubation.
|
8809173 |
| E6SM | IC50 |
1 μg/mL
|
Antiviral activity against vesicular stomatitis virus in E6SM human embryonic skin-muscle fibroblasts.
Antiviral activity against vesicular stomatitis virus in E6SM human embryonic skin-muscle fibroblasts.
|
8809173 |
| HeLa | IC50 |
0.4 μg/mL
|
Antiviral activity against vesicular stomatitis virus in HeLa cells.
Antiviral activity against vesicular stomatitis virus in HeLa cells.
|
8809173 |
| Vero | IC50 |
100 μg/mL
|
Cytostatic activity against Vero cells.
Cytostatic activity against Vero cells.
|
8809173 |
| E6SM | IC50 |
1 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against VSV virus expressed in E6SM cells
Antiviral and cytostatic effects against VSV virus expressed in E6SM cells
|
[PMID: 8809173] |
| E6SM | IC50 |
40 μg/mL
|
Cytostatic activity against E6SM human embryonic skin-muscle fibroblasts.
Cytostatic activity against E6SM human embryonic skin-muscle fibroblasts.
|
8809173 |
| E6SM | IC50 |
0.1 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against VV virus expressed in E6SM cells
Antiviral and cytostatic effects against VV virus expressed in E6SM cells
|
[PMID: 8809173] |
| HeLa | IC50 |
100 μg/mL
|
Cytostatic activity against HeLa cells.
Cytostatic activity against HeLa cells.
|
8809173 |
| FM3A | IC50 |
0.19 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects againstTK-VZV virus expressed in FM3A cells
Antiviral and cytostatic effects againstTK-VZV virus expressed in FM3A cells
|
[PMID: 8809173] |
| HEL | IC50 |
2 μg/mL
|
Cytostatic activity against HEL human embryonic lung fibroblasts.
Cytostatic activity against HEL human embryonic lung fibroblasts.
|
8809173 |
| HEL | IC50 |
1.5 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against CMV (AD-169) virus expressed in HEL cells
Antiviral and cytostatic effects against CMV (AD-169) virus expressed in HEL cells
|
[PMID: 8809173] |
| L1210 | IC50 |
0.25 μg/mL
|
Cytostatic activity against L1210 cells.
Cytostatic activity against L1210 cells.
|
8809173 |
| HEL | IC50 |
7 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against TK-VZV virus expressed in HEL cells
Antiviral and cytostatic effects against TK-VZV virus expressed in HEL cells
|
[PMID: 8809173] |
| FM3A | IC50 |
0.19 μg/mL
|
Cytostatic activity against FM3A cells.
Cytostatic activity against FM3A cells.
|
8809173 |
| HEL | IC50 |
10 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against VZV(Oka,YS) virus expressed in HEL cells
Antiviral and cytostatic effects against VZV(Oka,YS) virus expressed in HEL cells
|
[PMID: 8809173] |
| MOLT-4 | IC50 |
0.50 μg/mL
|
Cytostatic activity against MOLT-4 cells.
Cytostatic activity against MOLT-4 cells.
|
8809173 |
| HEL | IC50 |
2 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects againstTK-VZV virus expressed in HEL cells
Antiviral and cytostatic effects againstTK-VZV virus expressed in HEL cells
|
[PMID: 8809173] |
| HeLa | IC50 |
100 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against Coxsackie B4 virus expressed in HeLa cells
Antiviral and cytostatic effects against Coxsackie B4 virus expressed in HeLa cells
|
[PMID: 8809173] |
| HeLa | IC50 |
40 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against Polio-1 virus expressed in Hela cells
Antiviral and cytostatic effects against Polio-1 virus expressed in Hela cells
|
[PMID: 8809173] |
| HeLa | IC50 |
0.4 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against VSV virus expressed in Hela cells
Antiviral and cytostatic effects against VSV virus expressed in Hela cells
|
[PMID: 8809173] |
| L1210 | IC50 |
0.25 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects againstTK-VZV virus expressed in L1210 cells
Antiviral and cytostatic effects againstTK-VZV virus expressed in L1210 cells
|
[PMID: 8809173] |
| MOLT-4 | IC50 |
0.5 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects againstTK-VZV virus expressed in MOLT-4 cells
Antiviral and cytostatic effects againstTK-VZV virus expressed in MOLT-4 cells
|
[PMID: 8809173] |
| Vero | IC50 |
0.6 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against Junin virus expressed in Vero cells
Antiviral and cytostatic effects against Junin virus expressed in Vero cells
|
[PMID: 8809173] |
| Vero | IC50 |
2 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against Parainfluenza-3 virus expressed in Vero cells
Antiviral and cytostatic effects against Parainfluenza-3 virus expressed in Vero cells
|
[PMID: 8809173] |
| Vero | IC50 |
0.7 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against Reo-1 virus expressed in Vero cells
Antiviral and cytostatic effects against Reo-1 virus expressed in Vero cells
|
[PMID: 8809173] |
| Vero | IC50 |
100 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against forest virus expressed in Vero cells
Antiviral and cytostatic effects against forest virus expressed in Vero cells
|
[PMID: 8809173] |
| Vero | IC50 |
1 μg/mL
Compound: 1b (2-F-NPA)
|
Antiviral and cytostatic effects against Sindbis virus expressed in Vero cells
Antiviral and cytostatic effects against Sindbis virus expressed in Vero cells
|
[PMID: 8809173] |
| Vero | IC50 |
200 μg/mL
Compound: 1b (2-F-NPA)
|
Cytotoxic concentration required to reduce the number of Vero cells by 50%
Cytotoxic concentration required to reduce the number of Vero cells by 50%
|
[PMID: 8809173] |
In Vitro
2-Fluoroneplanocin A inhibits rabbit erythrocyte AdoHcy hydrolase with an IC50 of 0.20 μg/mL[1].
2-Fluoroneplanocin A (0.03-1.2 μg/mL; 37 h) inhibits vesicular stomatitis virus (IC50 = 0.25 μg/mL), measles virus (IC50 = 0.03 μg/mL), and mumps virus (IC50 = 1.2 μg/mL) in Vero cells, with no cytotoxicity at concentrations up to 200 μg/mL[1].
2-Fluoroneplanocin A exhibits potent antiviral activity against vaccinia virus (IC50 = 0.1 μg/mL), vesicular stomatitis virus (IC50 = 0.4-1 μg/mL), parainfluenza-3 (IC50 = 2 μg/mL), Reo-1 (IC50 = 0.7 μg/mL), Junin (IC50 = 0.6 μg/mL), and Tacaribe (IC50 = 0.7 μg/mL) across E6SM, HeLa, Vero, and HEL cell lines, with weaker or no activity against other tested viruses[1].
2-Fluoroneplanocin A inhibits the growth of HEL cells (IC50 = 2 μg/mL), L1210 cells (IC50 = 0.25 μg/mL), FM3A cells (IC50 = 0.19 μg/mL), MOLT-4 cells (IC50 = 0.50 μg/mL), and CEM cells (IC50 = 1.75 μg/mL), with weaker activity against E6SM, HeLa, and Vero cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 138751-31-2
-
Molecular Weight 281.24
-
Formula C11H12FN5O3
-
SMILES
NC1=NC(F)=NC2=C1N=CN2[C@H]3[C@H](O)[C@H](O)C(CO)=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)